
Nail biting, doom scrolling, compulsive shopping — users report these lifelong habits simply fading away alongside food cravings.
Based on 890+ community reports, GLP-1 agonists like Semaglutide appear to reduce various compulsive behaviors — not just food-related ones. Users report decreased nail biting, reduced doom scrolling, less compulsive shopping, and diminished gambling urges. This suggests GLP-1s work on fundamental reward pathways rather than just appetite-specific mechanisms.
“30 years of nail biting, gone. The same mechanism that kills food obsession killed this too.”
“The compulsion to keep watching 'just one more video' faded. My attention span feels normal again.”
“The compulsive shopping stopped too. Walked past a sale and felt nothing. That has never happened.”
The peptides most frequently mentioned in relation to this topic
Common questions about glp-1 agonists quieting compulsive behaviors
No, GLP-1 agonists are not approved for any behavioral or psychiatric conditions. These effects are unexpected, off-label observations from users.
No, not all users report this effect. It appears more common in people who had strong compulsive tendencies before starting treatment.
Reports vary. Some users maintain reduced compulsive behaviors after stopping, suggesting possible habit 'resetting.' Others see behaviors return.
Browse our complete database of peptides and community experiences
Research Disclaimer: This content compiles community-reported experiences and published research for informational purposes only. Peptides discussed are research chemicals, not FDA-approved medications. This is not medical advice. Always consult a qualified healthcare provider before considering any peptide use.